Montelukast might improve compliance with subcutaneous immunotherapy treatments in patients with allergic asthma
- PMID: 20850867
- DOI: 10.1016/j.jaci.2010.07.033
Montelukast might improve compliance with subcutaneous immunotherapy treatments in patients with allergic asthma
Comment on
-
Montelukast treatment may alter the early efficacy of immunotherapy in children with asthma.J Allergy Clin Immunol. 2010 Jun;125(6):1220-7. doi: 10.1016/j.jaci.2010.02.034. J Allergy Clin Immunol. 2010. PMID: 20434204 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
